Gene Delivery Technologies Market Report: Trends, Forecast and Competitive Analysis to 2030

Gene Delivery Technologies Trends and Forecast

The future of the global gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets. The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

A more than 150-page report is developed to help in your business decisions.

Gene Delivery Technologies by Segment

The study includes a forecast for the global gene delivery technologies by mode, method, application, and region.

Gene Delivery Technologies Market by Mode [Shipment Analysis by Value from 2018 to 2030]:

• Biological
• Chemical
• Physical

Gene Delivery Technologies Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Ex Vivo
• In Vivo
• In Vitro

Gene Delivery Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Gene Therapy
• Cell Therapy
• Vaccines
• Research

Gene Delivery Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Gene Delivery Technologies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gene delivery technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gene delivery technologies companies profiled in this report include-

• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys

Gene Delivery Technologies Market Insights

Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Within this market, gene therapy will remain the largest segment due to increasing adoption of gene-based therapies and growing number of clinical research initiatives.

North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Features of the Global Gene Delivery Technologies Market

Market Size Estimates: Gene delivery technologies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Gene delivery technologies market size by mode, method, application, and region in terms of value ($B).

Regional Analysis: Gene delivery technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different modes, methods, applications, and regions for the gene delivery technologies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gene delivery technologies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the gene delivery technologies market size?

Answer: The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030.

Q2. What is the growth forecast for gene delivery technologies market?

Answer: The global gene delivery technologies market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the gene delivery technologies market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

Q4. What are the major segments for gene delivery technologies market?

Answer: The future of the gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets.

Q5. Who are the key gene delivery technologies market companies?

Answer: Some of the key gene delivery technologies companies are as follows:

• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys

Q6. Which gene delivery technologies market segment will be the largest in future?

Answer: Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Q7. In gene delivery technologies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the gene delivery technologies market by mode (biological, chemical, and physical), method (ex vivo, in vivo, and in vitro), application (gene therapy, cell therapy, vaccines, and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?